Stock Information
Vir Biotechnology Inc (VIR)
Ticker Symbol: VIR
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $1,260.47 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.1639
Revenue (TTM): $0.49 M
Dividend Yield: N/A%
ROE: -49.31%
Latest News
-
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-Expansion Cohorts Evaluating PSMA-Targeted PRO-XTEN Dual-Masked T-Cell Engager VIR-5500 In Patients With Metastatic Prostate Cancer
Mon, Apr 13, 2026 3:06 PM
-
Vir Biotech Doses First Patient In Phase 1 Expansion Trial Of VIR-5500 For Metastatic Prostate Cancer
Mon, Apr 13, 2026 8:07 AM
-
Vir Biotechnology Announces First Patient Dosed in Phase 1 Dose-expansion Cohorts Evaluating PSMA-targeted, PRO-XTEN® Dual-masked T-cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer
Mon, Apr 13, 2026 8:06 AM
Key Financials
Financial data not available
